Search for stock quotes, financial statistics and more
Research Capital analyst Andre Uddin says Theralase Technologies’ (Theralase Technologies Stock Qu... Read More
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.70 target on ... Read More
Research Capital analyst Andre Uddin maintained a “Speculative Buy” rating and C$0.70 target pri... Read More
Research Capital analyst Andre Uddin maintained a “Speculative buy” rating and C$0.70 target pri... Read More
Following the company’s second quarter results, Research Capital analyst Andre Uddin is mainta... Read More
Share
Tweet
pin
Share